Analysis of HIV-1 reverse transcriptase and protease sequences in paired plasma and lymphoid tissue specimens from HIV-1 infected individuals

AIDS

Volumn 15, Issue 7, 2001, Pages 831-836

  Erice, Alejo ^a,b,c,d   Li, Wuyi ^a,b,c   Balfour Jr , Hank H ^a,b,c   Boies Jr , Lawrence R ^a,b,c   Melroe, Holly ^a,b,c   Henry, Keith ^a,b,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b REGIONS HOSPITAL   (United States)

^c Hospital Asepeyo   (Spain)

^d Box 437 Mayo ^*  (United States)

Author keywords

HIV 1 drug resistance mutations; Lymphoid tissue

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOID TISSUE; NUCLEOTIDE SEQUENCE; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEQUENCE HOMOLOGY; TONSIL;

HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LYMPHOID TISSUE; PROSPECTIVE STUDIES;

EID: 0035805242     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200105040-00003     Document Type: Article

References (20)

1. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
2. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
3. Quantitative image analysis of HIV-1 infection in lymphoid tissue
4. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
5. HIV-1 replication in patients with undetectable plasma virus receiving HAART
6. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy
7. Protease-inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
8. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure
9. Antiretroviral drug resistance testing in adults with HIV infection
10. Outpatient biopsies of the palatine tonsil: Access to lymphoid tissue for assessment of human immunodefciency virus RNA titers
11. Recovery and analysis of human immunodeficiency virus type 1 (HIV) RNA sequences from plasma samples with low HIV RNA levels
12. Antiretroviral drug resistance testing in adult HIV-1 infection
13. Quantitative detection of HIV-1 drug resistance mutations by automated DNA sequencing
14. Human immunodeficiency virus type 1 cloning vectors for antiretroviral resistance testing
15. Decreased human immunodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue
16. Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiretroviral therapy
17. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy
18. A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients
19. Zidovudine-resistant human immunodeficiency virus typ 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells
20. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection